Carmot Therapeutics has filed a notice of an exempt offering of securities to raise $149,999,802.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Carmot Therapeutics is raising $149,999,802.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Heather Turner played a key role…
